Physiological roles of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand

BioFactors

Volumn 35, Issue 1, 2009, Pages 88-97

  Sugiura, Takayuki ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

2 Arachidonoylglycerol; Anandamide monoacylglycerol; Cannabinoid; Lipid mediator

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; ARACHIDONIC ACID DERIVATIVE; CANNABINOID RECEPTOR; LIGAND;

BRAIN; CONTROLLED STUDY; IMMUNE SYSTEM; MAMMAL; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW; STRUCTURE ACTIVITY RELATION; ANIMAL; BIOLOGICAL MODEL; DRUG POTENTIATION; METABOLISM;

MAMMALIA; RATTUS;

ANIMALS; ARACHIDONIC ACIDS; GLYCERIDES; IMMUNE SYSTEM; LIGANDS; MODELS, BIOLOGICAL; RECEPTORS, CANNABINOID; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 65549124034     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.18     Document Type: Review

References (92)

1. Pertwee, R. G. (2004) Pharmacological actions of cannabinoids. In Cannabinoids. (Pertwee, R. G., ed.). Springer, Berlin, pp. 1-51.
2. Herkenham, M. (1995) Localization of cannabinoid receptors in brain and periphery. In Cannabinoid Receptors. (Pertwee, R. G., ed.). Academic Press, London, pp. 145-166.
3. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 298, 1946-1949.
4. Di Marzo, V., De Petrocellis, L., Bisogno, T., Berger, A., and Mechoulam, R. (2002) Biology of endocannabinoids. In Biology of Marijuana. (Onaivi, E. S., ed.). Taylor & Francis, London, pp. 125-173.
5. Di Marzo, V., De Petrocellis, L. and Bisogno, T. (2004) The biosynthesis, fate and pharmacological properties of endocannabinoid system. In Cannabinoids. (Pertwee, R. G., ed.). Springer, Berlin, pp. 147-185.
6. Sugiura, T., Oka, S., Ikeda, S., and Waku, K. (2006) Occurrence, biosynthesis, and metabolism of endocannabinoid. In Endocannabinoids: The Brain and Body's Marijuana and Beyond. (Onaivi, E. S., Sugiura, T., and Di Marzo, V., eds.). Taylor & Francis, Boca Raton, pp. 177-214.
7. Sugiura, T., Kishimoto, S., Oka, S., and Gokoh, M. (2006) Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog. Lipid Res. 45, 405-446.
8. Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., and Waku, K. (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215, 89-97.
9. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., Pertwee, R. G., Griffin, G., Bayewitch, M., Barg, J., and Vogel, Z. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83-90.
10. Sugiura, T., Kodaka, T., Nakane, S., Miyashita, T., Kondo, S., Suhara, Y., Takayama, H., Waku, K., Seki, C., Baba, N., and Ishima, Y. (1999) Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, etherlinked analogues, and related compounds. J. Biol. Chem. 274, 2794-2801.
11. Sugiura, T., Kondo, S., Kishimoto, S., Miyashita, T., Nakane, S., Kodaka, T., Suhara, Y., Takayama, H., and Waku, K. (2000) Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J. Biol. Chem. 275, 605-612.
12. Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E. J., Gangadharan, U., Hobbs, C., Di Marzo, V., and Doherty, P. (2003) Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain,J. Cell Biol. 163, 463-468.
13. Yoshida, M., Fukaya, M., Uchigashima, M., Miura, E., Kamiya, H., Kano, M., and Watanabe, M. (2006) Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J. Neurosci. 26, 4740-4751.
14. Karlsson, M., Contreras, J. A., Hellman, U., Tornqvist, H., and Holm, C. (1997) cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J. Biol. Chem. 272, 27218-27223.
15. Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., and Piomelli, D. (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. USA 99, 10819-10824. Erratum in 99 (2002), 13961. (Pubitemid 34907060)
16. Gulyas, A. I., Cravatt, B. F., Bracey, M. H., Dinh, T. P., Piomelli, D., Boscia, F., and Freund, T. F. (2004) Segregation of two endocannabinoid- hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur. J. Neurosci. 20, 441-458.
17. Makara, J. K., Mor, M., Fegley, D., Szabo, S. I., Kathuria, S., Astarita, G., Duranti, A., Tontini, A., Tarzia, G., Rivara, S., Freund, T. F., and Piomell, D. (2005) Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. Nat. Neurosci. 8, 1139-1141.
18. Di Marzo, V., Melck, D., Bisogno, T., and De Petrocellis, L. (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 21, 521-528. Erratum in 22 (1999), 80.
19. Sugiura, T., Kodaka, T., Kondo, S., Tonegawa, T., Nakane, S., Kishimoto, S., Yamashita, A., and Waku, K. (1997) Inhibition by 2-arachidonoylglycerol, a novel type of possible neuromodulator, of the depolarizationinduced increase in intracellular free calcium in neuroblastoma x glioma hybrid NG108-15 cells. Biochem. Biophys. Res. Commun. 233, 207-210.
20. Oka, S., Arai, A., Waku, K., Tokumura, A., and Sugiura, T. (2007) Depolarization-induced rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain synaptosomes. J. Biochem. 141, 687-697.
21. Ameri, A., and Simmet, T. (2000) Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices. Naunyn Schmiedebergs Arch. Pharmacol. 361, 265-272.
22. Sugiura, T., Kondo, S., Kodaka, T., Nakane, S., Yamashita, A., Kishimoto, S., Waku, K., and Ishima, Y. (1998) Biosynthesis and actions of anandamide and 2-arachidonoylglycerol: two endogenous cannabimimetic molecules. In Essential Fatty Acids and Eicosanoids. (Riemesma, R. A., Armstrong, R., Kelly, W., and Wilson, R., eds.). AOCS Press, Champaign, pp. 380-384.
23. Collins, D. R., Pertwee, R. G., and Davies, S. N. (1994) The action of synthetic cannabinoids on the induction of long-term potentiation in the rat hippocampal slice. Eur. J. Pharmacol. 259, R7-R8.
24. Stella, N., Schweitzer, P., and Piomelli, D. (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388, 773-778.
25. Kreitzer, A. C., and Regehr, W. G. (2001) Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29, 717-727.
26. Ohno-Shosaku, T., Maejima, T., and Kano, M. (2001) Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29, 729-738. (Pubitemid 32323945)
27. Wilson, R. I., and Nicoll, R. A. (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410, 588-592.
28. Melis, M., Perra, S., Muntoni, A. L., Pillolla, G., Lutz, B., Marsicano, G., Di Marzo, V., Gessa, G. L., and Pistis, M. (2004) Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. J. Neurosci. 24, 10707-10715.
29. Galante, M., and Diana, M. A. (2004) Group I metabotropic glutamate receptors inhibit GABA release at interneuron-Purkinje cell synapses through endocannabinoid production. J. Neurosci. 24, 4865-4874.
30. 2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cb4 signaling cascade in the cerebellum. J. Neurosci. 25, 6826-6835.
31. Jung, K. M., Mangieri, R., Stapleton, C., Kim, J., Fegley, D., Wallace, M., Mackie, K., and Piomelli, D. (2005) Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. Mol. Pharmacol. 68, 1196-1202.
32. Straiker, A., and Mackie, K. (2005) Depolarization-induced suppression of excitation in murine autaptic hippocampal neurons. J. Physiol. 569, 501-517.
33. Edwards, D. A., Kim, J., and Alger, B. E. (2006) Multiple mechanisms of endocannabinoid response initiation in hippocampus. J. Neurophysiol. 95, 67-75.
34. Safo, P. K., and Regehr, W. G. (2005) Endocannabinoids control the induction of cerebellar LTD. Neuron 48, 647-659.
35. Sinor, A. D., Irvin, S. M., and Greenberg, D. A. (2000) Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neurosci. Lett. 278, 157-160.
36. Panikashvili, D., Simeonidou, C., Ben-Shabat, S., Hanus, L., Breuer, A., Mechoulam, R., and Shohami, E. (2001) An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413, 527-531.
37. Panikashvili, D., Mechoulam, R., Beni, S. M., Alexandrovich, A., and Shohami, E. (2005) CB1 cannabinoid receptors are involved in neuroprotection via NF-jB inhibition. J. Cereb. Blood Flow Metab. 25, 477-484.
38. Baker, D., Pryce, G., Croxford, J. L., Brown, P., Pertwee, R. G., Huffman, J. W., and Layward, L. (2000) Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature 404, 84-87.
39. Baker, D., Pryce, G., Croxford, J. L., Brown, P., Pertwee, R. G., Makriyannis, A., Khanolkar, A., Layward, L., Fezza, F., Bisogno, T., and Di Marzo, V. (2001) Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J. 15, 300-302.
40. Cabranes, A., Venderova, K., de Lago, E., Fezza, F., Sanchez, A., Mestre, L., Valenti, M., Garcia-Merino, A., Ramos, J. A.Di Marzo, V., and Fernandez- Ruiz, J. (2005) Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. Neurobiol. Dis. 20, 207-217.
41. Maresz, K., Carrier, E. J., Ponomarev, E. D., Hillard, C. J., and Dittel, B. N. (2005) Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J. Neurochem. 95, 437-445.
42. Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Walker, J. M., Holmes, P. V., Crystal, J. D., Duranti, A., Tontini, A., Mor, M., Tarzia, G., and Piomelli, D. (2005) An endocannabinoid mechanism for stress-induced analgesia. Nature 435, 1108-1112.
43. Connell, K., Bolton, N., Olsen, D., Piomelli, D., and Hohmann, A. G. (2006) Role of the basolateral nucleus of the amygdala in endocannabinoid- mediated stress-induced analgesia. Neurosci. Lett. 397, 180-184.
44. Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Batkai, S., Jarai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., and Kunos, G. (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410, 822-825.
45. Kirkham, T. C., Williams, C. M., Fezza, F., and Di Marzo, V. (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br. J. Pharmacol. 136, 550-557.
46. Fride, E., Ginzburg, Y., Breuer, A., Bisogno, T., V.Di Marzo and Mechoulam, R. (2001) Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. Eur. J. Pharmacol. 419, 207-214.
47. Lee, M., Yang, K. H., and Kaminski, N. E. (1995) Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. J. Pharmacol. Exp. Ther. 275, 529-536.
48. Ouyang, Y., Hwang, S. G., Han, S. H., and Kaminski, N. E. (1998) Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells. Mol. Pharmacol. 53, 676-683.
49. Kobayashi, Y., Arai, S., Waku, K., and Sugiura, T. (2001) Activation by 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, of p42/44 mitogen-activated protein kinase in HL-60 cells. J. Biochem. 129, 665-669.
50. Kishimoto, S., Gokoh, M., Oka, S., Muramatsu, M., Kajiwara, T., Waku, K., and Sugiura, T. (2003) 2-Arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptordependent mechanism. J. Biol. Chem. 278, 24469-24475.
51. Zhao, Q., He, Z., Chen, N., Cho, Y. Y., Zhu, F., Lu, C., Ma, W. Y., Bode, A. M., and Dong, Z. (2005) 2-Arachidonoylglycerol stimulates activator protein-1-dependent transcriptional activity and enhances epidermal growth factor-induced cell transformation in JB6 P+ cells. J. Biol. Chem. 280, 26735-26742.
52. Chang, Y. H., Lee, S. T., and Lin, W. W. (2001) Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids. J. Cell. Biochem. 81, 715-723.
53. Gallily, R., Breuer, A., and Mechoulam, R. (2000) 2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-a production in murine macrophages, and in mice. Eur. J. Pharmacol. 406, R5-R7.
54. Facchinetti, F., Del Giudice, E., Furegato, S., Passarotto, M., and Leon, A. (2003) Cannabinoids ablate release of TNFa in rat microglial cells stimulated with lypopolysaccharide. Glia 41, 161-168.
55. Kishimoto, S., Kobayashi, Y., Oka, S., Gokoh, M., Waku, K., and Sugiura, T. (2004) 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells. J. Biochem. 135, 517-524.
56. Gokoh, M., Kishimoto, S., Oka, S., Mori, M., Waku, K., Ishima, Y., and Sugiura, T. (2005) 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells. Biochem. J. 386, 583-589. (Pubitemid 40445884)
57. Jorda, M. A., Verbakel, S. E., Valk, P. J., Vankan-Berkhoudt, Y. V., Maccarrone, M., Finazzi-Agro, A., Lowenberg, B., and Delwel, R. (2002) Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. Blood 99, 2786-2793.
58. Walter, L., Franklin, A., Witting, A., Wade, C., Xie, Y., Kunos, G., Mackie, K., and Stella, N. (2003) Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J. Neurosci. 23, 1398-1405.
59. Gokoh, M., Kishimoto, S., Oka, S., Metani, Y., and Sugiura, T. (2005) 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, enhances the adhesion of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes. FEBS Lett. 579, 6473-6478. (Pubitemid 41612170)
60. Gokoh, M., Kishimoto, S., Oka, S. and Sugiura, T. (2007) 2-Arachidonoylglycerol enhances the phagocytosis of opsonized zymosan by HL-60 cells differentiated into macrophage-like cells. Biol. Pharm. Bull. 30, 1199-1205.
61. Oka, S., Yanagimoto, S., Ikeda, S., Gokoh, M., Kishimoto, S., Waku, K., Ishima, Y., and Sugiura, T. (2005) Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear. J. Biol. Chem. 280, 18488-18497.
62. Oka, S., Wakui, J., Ikeda, S., Yanagimoto, S., Kishimoto, S., Gokoh, M., Nasui, M., and Sugiura, T. (2006) Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice. J. Immunol. 177, 8796-8805.
63. Iwamura, H., Suzuki, H., Ueda, Y., Kaya, T., and Inaba, T. (2001) In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor. J. Pharmacol. Exp. Ther. 296, 420-425.
64. Ueda, Y., Miyagawa, N., Matsui, T., Kaya, T., and Iwamura, H. (2005) Involvement of cannabinoid CB2 receptor-mediated response and efficacy of cannabinoid CB2 receptor inverse agonist, JTE-907, in cutaneous inflammation in mice. Eur. J. Pharmacol. 520, 164-171.
65. Sofia, R. D., Nalepa, S. D., Harakal, J. J., and Vassar, H. B. (1973) Antiedema and analgesic properties of D9-tetrahydrocannabinol (THC). J. Pharmacol. Exp. Ther. 186, 646-655.
66. Bayewitch, M.Rhee, M. H., Avidor-Reiss, T.Breuer, A.Mechoulam, R., and Vogel, Z. (1996) (-)-Δ9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase. J. Biol. Chem. 271, 9902-9905.
67. Pacher, P., Batkai, B., and Kunos, G. (2004) Cardiovascular pharmacology of cannabinoids. In Cannabinoids. (Pertwee, R. G., ed.). Springer, Berlin, pp. 599-625.
68. Sugiura, T., Kodaka, T., Nakane, S., Kishimoto, S., Kondo, S., and Waku, K. (1998) Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator? Biochem. Biophys. Res. Commun. 243, 838-843.
69. Mechoulam, R., Fride, E., Ben-Shabat, S., Meiri, U., and Horowitz, M. (1998) Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid. Eur. J. Pharmacol. 362, R1
70. Deutsch, D. G., Goligorsky, M. S., Schmid, P. C., Krebsbach, R. J., Schmid, H. H. O., Das, S. K., Dey, S. K., Arreaza, G., Thorup, C., Stefano, G., and Moore, J. C. (1997) Production and physiological actions of anandamide in the vasculature of the rat kidney. J. Clin. Invest. 100, 1538-1546.
71. Stefano, G. B., Bilfinger, T. V., Rialas, C. M., and Deutsch, D. G. (2000) 2-Arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1. Pharmacol. Res. 42, 317-322.
72. Chen, Y., McCarron, R. M., Ohara, Y., Bembry, J., Azzam, N., Lenz, F. A., Shohami, E., Mechoulam, R., and Spatz, M. (2000) Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1. Circ. Res. 87, 323-327.
73. Kagota, S., Yamaguchi, Y., Nakamura, K., Sugiura, T., Waku, K., and Kunitomo, M. (2001) 2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor. Eur. J. Pharmacol. 415, 233-238.
74. Jarai, Z., Wagner, J. A., Goparaju, S. K., Wang, L., Razdan, R. K., Sugiura, T., Zimmer, A. M., Bonner, T. I., Zimmer, A., and Kunos, G. (2000) Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice. Hypertension 35, 679-684.
75. Wagner, J. A., Hu, K., Bauersachs, J., Karcher, J., Wiesler, M., Goparaju, S. K., Kunos, G., and Ertl, G. (2001) Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. J. Am. Coll. Cardiol. 38, 2048-2054.
76. Bouchard, J. F., Lepicier, P., and Lamontagne, D. (2003) Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart,Life Sci. 72, 1859-1870.
77. Lepicier, P., Bouchard, J. F., Lagneux, C., and Lamontagne, D. (2003) Endocannabinoids protect the rat isolated heart against ischaemia. Br. J. Pharmacol. 139, 805-815.
78. Darmani, N. A. (2006) Endocannabinoids and gastrointestinal function. In Endocannabinoids: The Brain and Body's Marijuana and Beyond. (Onaivi, E. S., Sugiura, T., and Di Marzo, V., eds.). Taylor & Francis, Boca Raton, pp. 395-419.
79. Izzo, A. A., and Coutts, A. A. (2004) Cannabinoids and the digestive tract. In Cannabinoids. (Pertwee, R. G., ed.). Springer, Berlin, pp. 573-598.
80. Izzo, A. A., Fezza, F., Capasso, R., Bisogno, T., Pinto, L., Iuvone, T., Esposito, G., Mascolo, N., Di Marzo, V., and Capasso, F. (2001) Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. Br. J. Pharmacol. 134, 563-570.
81. Mascolo, N., Izzo, A. A., Ligresti, A., Costagliola, A., Pinto, L., Cascio, M. G., Maffia, P., Cecio, A., Capasso, F., and Di Marzo, V. (2002) The endocannabinoid system and the molecular basis of paralytic ileus in mice. FASEB J. 16, 1973-1975.
82. Izzo, A. A., Capasso, F., Costagliola, A., Bisogno, T., Marsicano, G., Ligresti, A., Matias, I., Capasso, R., Pinto, L., Borrelli, F., Cecio, A., Lutz, B., Mascolo, N., and Di Marzo, V. (2003) An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice. Gastroenterology 125, 765-774.
83. Harada, N., Nemoto, K., Okamura, T., Ninomiya, N., and Suzuki, H., Yamamoto, Y. (2005) Effects of cannabinoids on colonic muscle contractility and tension in guinea pigs. J. Nippon Med. Sch. 72, 43-51.
84. Cota, D. (2008) Role of the endocannabinoid system in energy balance regulation and obesity,Front. Horm. Res. 36, 135-145.
85. Matias, I., and Di Marzo, V. (2007) Endocannabinoids and the control of energy balance. Trends Endocrinol. Metab. 18, 27-37.
86. De Petrocellis, L., Melck, D., Palmisano, A., Bisogno, T., Laezza, C., Bifulco, M., and Di Marzo, V. (1998) The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc. Natl. Acad. Sci. USA 95, 8375-8380.
87. Melck, D., De Petrocellis, L., Orlando, P., Bisogno, T., Laezza, C., Bifulco, M., and Di Marzo, V. (2000) Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology 141, 118-126.
88. Ligresti, A., Bisogno, T., Matias, I., De Petrocellis, L., Cascio, M. G., Cosenza, V., D'argenio, G., Scaglione, G., Bifulco, M., Sorrentini, I., and Di Marzo, V. (2003) Possible endocannabinoid control of colorectal cancer growth. Gastroenterology 125, 677-687.
89. Fowler, C. J., Jonsson, K. O., Andersson, A., Juntunen, J., Jarvinen, T., Vandevoorde, S., Lambert, D. M., Jerman, J. C., and Smart, D. (2003) Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid. Biochem. Pharmacol. 66, 757-767.
90. Jacobsson, S. O., Wallin, T., and Fowler, C. J. (2001) Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors. J. Pharmacol. Exp. Ther. 299, 951-959.
91. Nithipatikom, K., Endsley, M. P., Isbell, M. A., Falck, J. R., Iwamoto, Y., Hillard, C. J., and Campbell, W. B. (2004) 2-Arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. Cancer Res. 64, 8826-8830.
92. Nithipatikom, K., Endsley, M. P., Isbell, M. A., Wheelock, C. E., Hammock, B. D., and Campbell, W. B. (2005) A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells. Biochem. Biophys. Res. Commun. 332, 1028-1033.